Neuronetics, Inc.
General ticker "STIM" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $98.5M (TTM average)
Neuronetics, Inc. does not follow the US Stock Market performance with the rate: -18.3%.
Estimated limits based on current volatility of 6.6%: low 1.78$, high 2.04$
Factors to consider:
- Total employees count: 203 (+4.6%) as of 2023
- Top business risk factors: Lack of profitability, Managing rapid expansion, Market competition, Labor/talent shortage/retention, Implementation of new systems or technology
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.79$, 2.56$]
- 2025-12-31 to 2026-12-31 estimated range: [0.89$, 2.79$]
Financial Metrics affecting the STIM estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -68.52 <= 0.04
- Positive: 19.35 < Shareholder equity ratio, % of 19.66 <= 42.53
- Positive: Inventory ratio change, % of -4.13 <= -0.76
- Negative: negative Industry operating cash flow (median)
- Positive: -14.19 < Investing cash flow per share per price, % of -5.33
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
Short-term STIM quotes
Long-term STIM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $65.21MM | $71.35MM | $74.89MM |
| Operating Expenses | $100.32MM | $101.90MM | $109.45MM |
| Operating Income | $-35.11MM | $-30.55MM | $-34.56MM |
| Non-Operating Income | $-2.05MM | $0.36MM | $-9.18MM |
| Interest Expense | $4.25MM | $5.42MM | $7.29MM |
| R&D Expense | $9.34MM | $9.52MM | $12.77MM |
| Income(Loss) | $-37.16MM | $-30.19MM | $-43.74MM |
| Taxes | $0.00MM | $0.00MM | $-0.01MM |
| Profit(Loss)* | $-37.11MM | $-30.21MM | $-43.71MM |
| Stockholders Equity | $57.06MM | $34.19MM | $27.71MM |
| Inventory | $8.90MM | $8.09MM | $4.25MM |
| Assets | $116.88MM | $115.83MM | $140.90MM |
| Operating Cash Flow | $-30.74MM | $-32.04MM | $-31.00MM |
| Capital expenditure | $3.27MM | $2.37MM | $1.47MM |
| Investing Cash Flow | $6.73MM | $-1.32MM | $-2.41MM |
| Financing Cash Flow | $0.21MM | $22.70MM | $-6.81MM |
| Earnings Per Share** | $-1.38 | $-1.05 | $-1.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.